Alerts will be sent to your verified email
Verify Email
DRAGARWQ
|
Dr Agarwals Eye Hsp
|
Apollo Hospital Ent.
|
Max Healthcare Inst
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
23.27 % | 13.17 % | 9.23 % |
|
5yr average Equity Multiplier
|
3.54 | 2.58 | 1.48 |
|
5yr Average Asset Turnover Ratio
|
0.65 | 1.01 | 0.42 |
|
5yr Avg Net Profit Margin
|
10.6 % | 4.98 % | 13.79 % |
|
Price to Book
|
8.45 | 11.08 | 10.53 |
|
P/E
|
42.19 | 60.28 | 78.0 |
|
5yr Avg Cash Conversion Cycle
|
-246.9 Days | -20.18 Days | -143.35 Days |
|
Inventory Days
|
10.95 Days | 10.12 Days | 5.36 Days |
|
Days Receivable
|
12.36 Days | 46.32 Days | 29.86 Days |
|
Days Payable
|
321.32 Days | 72.66 Days | 185.68 Days |
|
5yr Average Interest Coverage Ratio
|
5.74 | 4.04 | 11.19 |
|
5yr Avg ROCE
|
15.68 % | 12.23 % | 10.55 % |
|
5yr Avg Operating Profit Margin
|
27.52 % | 12.88 % | 23.93 % |
|
5 yr average Debt to Equity
|
0.4 | 0.53 | 0.15 |
|
5yr CAGR Net Profit
|
n/a | 57.25 % | n/a |
|
5yr Average Return on Assets
|
6.35 % | 5.14 % | 6.36 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.67 % | 28.02 % | 23.74 % |
|
Share Pledged by Promoters
|
29.26 % | 8.58 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.76 % | -1.31 % | -0.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.18 % | 7.66 % | -6.61 % |
|
Dr Agarwals Eye Hsp
|
Apollo Hospital Ent.
|
Max Healthcare Inst
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
Therapeutic Area Wise Break-Up - Domestic
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|